US Neurosurgical (USNU)

Overall impact
C (59)

Commentary

US Neurosurgical is an average overall performer. With a 'C' rating of 59.1 for overall impact (61st percentile compared to all companies), US Neurosurgical ranks 42nd out of 71 industry peers, behind ModivCare, Ontrak, Hanger and 38 others, and ahead of Bumrungrad Hospital, Rede D'Or São Luiz, Anne Arundel Dermatology and 26 others. On top material causes for US Neurosurgical's industry (Healthcare Providers), US Neurosurgical performs well in Child and Maternal Health (81.3 score), Child and Maternal Health (83.6), Humane Treatment of Animals (95.6) and 3 other causes where it received an 'A' score and performs poorly in Quality Lifelong Education (11.4 score), No Poverty (34.3), Sanitation Access (24.0) and 1 other cause where it received a 'D' or 'F' score.
Impact
Cause USNU
Peer rank
Overall impact

Log in to view this information

Impact trend

Change in rating for overall impact

Log in to view this information

Company
Founded
1993
Employees
3
Sector
Health Care
Industry
Health Care Providers & Services
Sub-industry
Health Care Services
SASB industry
Health Care Delivery
Headquarters
Ca, United States
Share classes
USNU
Description
Elite Health Systems Inc., through its subsidiaries, develops a business to provide Medicare Advantage plans and related services in California and Nevada. The company was formerly known as U.S. NeuroSurgical Holdings, Inc. and changed its name to Elite Health Systems Inc. in September 2024. Elite Health Systems Inc. was founded in 1993 and is headquartered in Ontario, California.
Material causes
Ethos considers the following causes material for US Neurosurgical, based on its industry sub-industry Health Care Services. Learn more about material causes in our methodology overview.

This information is subject to Ethos' Terms and Conditions, which you can find here.

This information may not be used for corporate financing purposes (including, without limitation, ESG-linked loans, credit facilities, securities or structured products), as a basis for any financial instruments or products (including, without limitation, passively managed funds and index-linked derivative securities) or other products or services, to verify or correct data in any other compilation of data or index, to create any derivative works, nor to create any other data or index (custom or otherwise), without Ethos' prior written permission.

By browsing this site you agree to our use of cookies. Read more.
We use cookies on this site to enhance your user experience. By continuing to browse the site, you are agreeing to our use of cookies. Give me more info.